A disconnect between upstream and downstream work continues to hold back progress in biomanufacturing, claims the CEO of ...

Bora Biologics, a subsidiary of Tanvex Biopharma born out of a spinoff from Bora Pharmaceuticals, is expanding CDMO operations at its San Diego facility. The new project will add 8,075 square feet of ...

The Global Single-use Bioreactors Market is set to witness a healthy growth rate of 20% by 2029. Technological innovations ...

or other organic components from the fermentation broth are exposed to high temperatures and burn or caramelize].” Meanwhile, being able to design bioreactors “with an expanded design space means you ...

“We focus on the good of the cells and designed and built all of the components of our bioreactor with that in mind,” says Thomas Schwarz, a scientist at Fraunhofer TLC-RT. For example, one crucial ...

In upstream bioprocessing, the cell type is chosen as a function of the desired product; the media components, type of bioreactor and scaling are also defined. The subsequent step is the harvesting of ...

The issues with the bioreactors, key components of Upside’s intellectual property stack, have so far proven arduous. And though Upside is still working on designs for a replacement model ...